Dyslipidemia: Statins and risk of diabetes mellitus

Nature Reviews Cardiology

Volumn 9, Issue 10, 2012, Pages 552-

  Mearns, Bryony M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN;

BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; NOTE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; UNSTABLE ANGINA PECTORIS;

EID: 84866736418     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2012.126     Document Type: Note

References (2)

1. Wang, K.-L. et al. Statins, risk of diabetes, and implications on outcomes in the general population. J. Am. Coll. Cardiol. doi:10.1016/j.jacc. 2012.05.019
2. Ridker, P. M. et al. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 380, 565-571 (2012)